Search Results for: news

Why investors are going gaga over a tiny, $35 computer

London (CNN) — Investors are snapping up the shares of a British maker of tiny computers after it went public on the London Stock Exchange Tuesday.Raspberry Pi stock soared as much as 40% in early trade before paring those gains…

The hidden costs of owning a home are surging for Americans

New York (CNN) — The price for owning a home is rising rapidly – and we’re not just talking about mortgage payments.US homeowners are now paying an average of $18,118 a year on property taxes, homeowners’ insurance, maintenance, energy and…

Alzheimer's drug that can slow disease gets backing from FDA advisers

Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia. The FDA will make the final decision on approval later this year. If the agency agrees with its advisers, the drug would only be the second Alzheimer’s drug approved to slow cognitive decline due to Alzheimer’s. Despite discrepancies in how Lilly studied its drug, the panel says it should be approved broadly for various patients with the disease. The FDA approved a similar infused drug, Leqembi, last year.